Related content

Prognostic Value of p53 and Proliferating Cell Nuclear Antigen Expression in Endometrial Carcinoma

By Hamel N.W.   Sebo T.J.   Wilson T.O.   Keeney G.L.   Roche P.C.   Suman V.J.   Hu T.C.   Podratz K.C.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 192-198

Academic Press

Access to resources Recommend Favorite

Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma

By Llanos M.   Alvarez-Argüelles H.   Alemán R.   Oramas J.   Díaz-Flores L.   Batista N.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 15-22

Humana Press, Inc

Access to resources Recommend Favorite

Expression of Topoisomerase IIα, Ki-67, Proliferating Cell Nuclear Antigen, p53, and Argyrophilic Nucleolar Organizer Regions in Vulvar Squamous Lesions

By Brustmann H.   Naudé S.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 192-199

Academic Press

Access to resources Recommend Favorite

p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder - Possible clinical implications

By Friedrich M.G.   Schwaibold H.   Wintzer O.   Pichlmeier U.   Huland H.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 4, 1997-07 ,pp. : 125-131

Elsevier

Access to resources Recommend Favorite

p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma

By Olumi A.F.   Weidner N.   Presti J.C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 2, 2001-03 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite